Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.53 USD | -7.11% | -4.08% | -14.73% |
05-08 | Transcript : Relmada Therapeutics, Inc., Q1 2024 Earnings Call, May 08, 2024 | |
05-08 | Relmada Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.73% | 107M | |
+3.91% | 109B | |
+10.87% | 105B | |
+0.23% | 22.25B | |
-13.14% | 22.09B | |
-7.68% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- RLMD Stock
- News Relmada Therapeutics, Inc.
- Relmada Therapeutics Doses First Person in Phase 3 Trial of REL-1017 for Major Depressive Disorder